![Giles Robinson: We’re enrolling infants and young children with medulloblastoma on SJiMB21](https://oncodaily.com/pub/uploads/2023/11/Gilles-Robinson-1280x854.jpeg)
Photo from Gilles Robinson/X
Dec 22, 2023, 14:14
Giles Robinson: We’re enrolling infants and young children with medulloblastoma on SJiMB21
Giles Robinson, Neuro-Oncology Division Director at the St. Jude Children’s Research Hospital, shared on X/Twitter:
“Medulloblastoma is the most common malignant childhood brain tumor. We’re enrolling infants and young children with medulloblastoma on SJiMB21, a trial that tailors treatment based on the tumor’s molecular group, subgroup and clinical risk.”
For more details, click here.
Source: Giles Robinson/X